Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | GAA | P10253 | 1/20 | 0.51 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.50 |
| ▸ | SRC | P12931 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.45 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.43 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10540988 | 1.00 | ALDH1A1 (0.51) | ALDH1A1GAACYP2D6SRCLMNA | |
| SCHEMBL222001 | 1.00 | ALDH1A1 (0.51) | ALDH1A1GAACYP2D6SRCLMNA | |
| Hydrochloric Acid SCHEMBL2554908 | 0.98 | ALDH1A1 (0.50) | ALDH1A1GAACYP2D6SRCLMNA | |
| Hydrochloric Acid SCHEMBL571538 | 0.98 | ALDH1A1 (0.50) | ALDH1A1GAACYP2D6SRCLMNA | |
| Hydrochloric Acid SCHEMBL2552119 | 0.98 | ALDH1A1 (0.50) | ALDH1A1GAACYP2D6SRCLMNA | |
| SCHEMBL18510081 | 0.86 | SRC (0.50) | ALDH1A1GAACYP2D6SRCLMNA | |
| SCHEMBL3329130 | 0.84 | ALDH1A1 (0.50) | ALDH1A1GAACYP2D6SRCLMNA | |
| SCHEMBL8921482 | 0.84 | ALDH1A1 (0.50) | ALDH1A1GAACYP2D6SRCLMNA | |
| SCHEMBL30900470 | 0.84 | SRC (0.48) | ALDH1A1GAACYP2D6SRCLMNA | |
| SCHEMBL8273288 | 0.84 | ALDH1A1 (0.50) | ALDH1A1GAACYP2D6SRCLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 106 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025076437-A1 | CHEMICALLY REVERSIBLE 2´-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-04-10 | — | — | WO | claimed |
| US-20240093184-A1 | CHEMICALLY REVERSIBLE 2`-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-03-21 | — | — | US | claimed |
| CN-111777520-B | Synthesis method of multi-substituted dimethylamino phenyl acetic acid compound | 苏州爱玛特生物科技有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-111777520-A | Synthesis method of multi-substituted dimethylamino phenyl acetic acid compound | 苏州爱玛特生物科技有限公司 | 2020-10-16 | — | — | CN | claimed |
| US-6353041-B1 | PLASTICS FOR SEALING ROOTS OF TEETH | KERR CORPORATION | 2002-03-05 | — | — | US | claimed |
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2025-11-13 | — | — | US | disclosed |
| WO-2025076437-A1 | CHEMICALLY REVERSIBLE 2´-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2025-04-10 | — | — | WO | disclosed |
| EP-4532484-A1 | ROCK INHIBITORS AND USES THEREOF | DIZAL (JIANGSU) PHARMACEUTICAL CO., LTD. (CN) | 2025-04-09 | — | — | EP | disclosed |
| US-20250019377-A1 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2025-01-16 | — | — | US | disclosed |
| CN-119173509-A | ROCK inhibitors and uses thereof | 迪哲(江苏)医药股份有限公司 | 2024-12-20 | — | — | CN | disclosed |
| US-20240376128-A1 | N-CYCLOPROPYLPYRIDO [4, 3-D] PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF | JACOBIO PHARMACEUTICALS CO., LTD. (CN) | 2024-11-14 | — | — | US | disclosed |
| EP-4387967-A1 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | Jacobio Pharmaceuticals Co., Ltd. (CN) | 2024-06-26 | — | — | EP | disclosed |
| US-5855971-A | Liquid crystalline optical film, compensating film for liquid crystal display comprising the liquid crystalline optical film, and liquid crystal display having the compensating film | NIPPON OIL COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0758013-A1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-12 | — | — | EP | disclosed |
| US-5463077-A | Exhibit substance P antagonist activity | RHONE-POULENC RORER S.A. (FR) | 1995-10-31 | — | — | US | disclosed |
| US-4846877-A | CYCLIC DIMERS OF PHENYLGLYCINE | TEIJIN LIMITED (JP) | 1989-07-11 | — | — | US | disclosed |
| US-4772314-A | PHENYLGLYCINES, MONOMERIC | TEIJIN LIMITED (JP) | 1988-09-20 | — | — | US | disclosed |
| US-4486179-A | ESTERS OF SYRINGIC ACID AS ANTICARIES AGENTS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1984-12-04 | — | — | US | disclosed |
| US-4268525-A | Amidoximether insecticides | MOBIL OIL CORPORATION (US) | 1981-05-19 | — | — | US | disclosed |
| US-4069385-A | FROM AN OLEFIN AND AN ORGANIC PEROXIDE WITH COPPER-SCHIFF BASE COMPEX AS CATALYST | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1978-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250346616-A1 | ROCK INHIBITORS AND USES THEREOF | ROCK1, ROCK2, RHOA | ALDH1A1 2229/4885GAA 966/4885CYP2D6 3580/4885 |
| US-20250019377-A1 | 1, 4-OXAZEPANE DERIVATIVES AND USES THEREOF | CYP11B2, CYP21A2, CYP11B1 | ALDH1A1 354/4885GAA 774/4885CYP2D6 32/4885 |
| US-20240376128-A1 | N-CYCLOPROPYLPYRIDO [4, 3-D] PYRIMIDIN-4-AMINE DERIVATIVES AND USES THEREOF | CYP4A11, CYP4B1, DHPS | ALDH1A1 311/4885GAA 1775/4885CYP2D6 8/4885 |
| US-20240093184-A1 | CHEMICALLY REVERSIBLE 2`-OH ACYLATION PROTECTS RNA FROM HYDROLYTIC AND ENZYMATIC DEGRADATION | RNGTT, NSUN2, NSUN3 | ALDH1A1 1562/4885GAA 742/4885CYP2D6 2587/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.